共有 50 笔近期内部人交易记录记录，涉及 Cellectar Biosciences, Inc. (CLRB), 包括 46 笔买入 和 3 笔卖出. 内部人买入总额为 $8.96M 内部人卖出总额为 $731.99.
近期活跃的重要内部人包括 Neis John, Caruso James V, Longcor Jarrod. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — CLRB
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2025-12-12 |
Neis John |
Director |
知情卖出 |
198 |
$3.70 |
$731.99 |
10 |
| 2025-07-02 |
Caruso James V |
Chief Executive Officer |
知情买入 |
10,000 |
$5.25 |
$52.5K |
10,000 |
| 2025-07-02 |
Longcor Jarrod |
Chief Operating Officer |
知情买入 |
10,000 |
$5.25 |
$52.5K |
10,000 |
| 2025-07-02 |
Kolean Chad J |
Chief Financial Officer |
知情买入 |
5,000 |
$5.25 |
$26.25K |
5,000 |
| 2025-02-14 |
Driscoll Frederick W |
Director |
限制性股票授予 (RSU) |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Neis John |
Director |
限制性股票授予 (RSU) |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Caruso James V |
President and CEO |
限制性股票授予 (RSU) |
900,000 |
$0.29 |
$261K |
900,000 |
| 2025-02-14 |
Swirsky Douglas J |
Director |
限制性股票授予 (RSU) |
90,000 |
$0.29 |
$26.1K |
90,000 |
| 2025-02-14 |
Loren Stefan |
Director |
限制性股票授予 (RSU) |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Longcor Jarrod |
Chief Operating Officer |
限制性股票授予 (RSU) |
500,000 |
$0.29 |
$145K |
500,000 |
| 2025-02-14 |
Kolean Chad J |
Chief Financial Officer |
限制性股票授予 (RSU) |
290,000 |
$0.29 |
$84.1K |
290,000 |
| 2025-02-14 |
Chanan-khan Asher |
Director |
限制性股票授予 (RSU) |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-01-10 |
Longcor Jarrod |
Chief Operating Officer |
知情买入 |
30,000 |
$0.28 |
$8.4K |
83,141 |
| 2024-06-14 |
Driscoll Frederick W |
Director |
限制性股票授予 (RSU) |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Neis John |
Director |
限制性股票授予 (RSU) |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Caruso James V |
President and CEO |
限制性股票授予 (RSU) |
900,000 |
$2.65 |
$2.39M |
900,000 |
| 2024-06-14 |
Swirsky Douglas J |
Director |
限制性股票授予 (RSU) |
90,000 |
$2.58 |
$232.2K |
90,000 |
| 2024-06-14 |
Loren Stefan |
Director |
限制性股票授予 (RSU) |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Longcor Jarrod |
Chief Operating Officer |
限制性股票授予 (RSU) |
500,000 |
$2.65 |
$1.33M |
500,000 |
| 2024-06-14 |
Kolean Chad J |
Chief Financial Officer |
限制性股票授予 (RSU) |
290,000 |
$2.65 |
$768.5K |
290,000 |
| 2024-06-14 |
Chanan-khan Asher |
Director |
限制性股票授予 (RSU) |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Lea Darrell Shane |
Chief Commercial Officer |
限制性股票授予 (RSU) |
260,000 |
$2.65 |
$689K |
260,000 |
| 2024-06-14 |
Shustov Andrei |
Senior Vice President, Medical |
限制性股票授予 (RSU) |
260,000 |
$2.65 |
$689K |
260,000 |
| 2023-12-08 |
Caruso James V |
President and CEO |
限制性股票授予 (RSU) |
40,596 |
- |
- |
49,236 |
| 2023-12-08 |
Longcor Jarrod |
Chief Operating Officer |
限制性股票授予 (RSU) |
42,927 |
- |
- |
53,141 |
| 2023-12-08 |
Kolean Chad J |
Chief Financial Officer |
限制性股票授予 (RSU) |
42,554 |
- |
- |
42,578 |
| 2023-12-08 |
Lea Darrell Shane |
Chief Commercial Officer |
限制性股票授予 (RSU) |
39,599 |
- |
- |
39,599 |
| 2023-12-08 |
Shustov Andrei |
Senior Vice President, Medical |
限制性股票授予 (RSU) |
47,856 |
- |
- |
55,038 |
| 2023-06-28 |
Driscoll Frederick W |
Director |
限制性股票授予 (RSU) |
25,000 |
$1.85 |
$46.25K |
47,650 |
| 2023-06-28 |
Neis John |
Director |
限制性股票授予 (RSU) |
25,000 |
$1.85 |
$46.25K |
47,887 |
| 2023-06-28 |
Swirsky Douglas J |
Director |
限制性股票授予 (RSU) |
37,500 |
$1.85 |
$69.38K |
71,925 |
| 2023-06-28 |
Loren Stefan |
Director |
限制性股票授予 (RSU) |
25,000 |
$1.85 |
$46.25K |
47,885 |
| 2023-06-28 |
Chanan-khan Asher |
Director |
限制性股票授予 (RSU) |
25,000 |
$1.85 |
$46.25K |
40,600 |
| 2023-06-23 |
Caruso James V |
President and CEO |
限制性股票授予 (RSU) |
261,000 |
$1.68 |
$438.48K |
261,000 |
| 2023-06-23 |
Longcor Jarrod |
Chief Operating Officer |
限制性股票授予 (RSU) |
144,000 |
$1.68 |
$241.92K |
144,000 |
| 2023-06-23 |
Kolean Chad J |
Chief Financial Officer |
限制性股票授予 (RSU) |
104,000 |
$1.68 |
$174.72K |
104,000 |
| 2023-06-23 |
Lea Darrell Shane |
Chief Commercial Officer |
限制性股票授予 (RSU) |
100,000 |
$1.68 |
$168K |
100,000 |
| 2023-02-15 |
Shustov Andrei |
Senior Vice President, Medical |
处置 |
- |
- |
- |
7,182 |
| 2023-02-15 |
Shustov Andrei |
Senior Vice President, Medical |
限制性股票授予 (RSU) |
100,000 |
$1.67 |
$167K |
100,000 |
| 2023-01-17 |
Caruso James V |
President and CEO |
限制性股票授予 (RSU) |
261,000 |
- |
- |
261,000 |
| 2023-01-17 |
Longcor Jarrod |
Chief Operating Officer |
限制性股票授予 (RSU) |
144,000 |
- |
- |
144,000 |
| 2023-01-17 |
Kolean Chad J |
Chief Financial Officer |
限制性股票授予 (RSU) |
104,000 |
- |
- |
104,000 |
| 2022-11-21 |
Lea Darrell Shane |
Officer |
未知 |
- |
- |
- |
- |
| 2022-11-21 |
Lea Darrell Shane |
Chief Commercial Officer |
限制性股票授予 (RSU) |
100,000 |
- |
- |
100,000 |
| 2022-06-24 |
Driscoll Frederick W |
Director |
限制性股票授予 (RSU) |
7,800 |
- |
- |
7,800 |
| 2022-06-24 |
Neis John |
Director |
限制性股票授予 (RSU) |
7,800 |
- |
- |
7,800 |
| 2022-06-24 |
Swirsky Douglas J |
Director |
限制性股票授予 (RSU) |
11,700 |
$4.10 |
$47.97K |
11,700 |
| 2022-06-24 |
Loren Stefan |
Director |
限制性股票授予 (RSU) |
7,800 |
$4.10 |
$31.98K |
7,800 |
| 2022-06-24 |
Chanan-khan Asher |
Director |
限制性股票授予 (RSU) |
7,800 |
- |
- |
7,800 |
| 2022-02-24 |
Kolean Chad J |
Chief Financial Officer |
处置 |
- |
- |
- |
240 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
